Sat, Mar 17, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

CAIA Association Forms Alliance with New York Hedge Fund Roundtable

Monday, May 23, 2011
The Chartered Alternative Investment Analyst (CAIA) Association, sponsor of the CAIA designation, the highest standard of education in alternative investments, has formed an alliance with the New York Hedge Fund Roundtable. Through this alliance, CAIA has become the official designation of the Roundtable and members of the Roundtable will receive a 10 percent discount on standard exam registration fees for both levels of the CAIA exams.

“The Roundtable is excited to align itself with the CAIA Association, whose program is the gold standard for education in the alternative investment community and whose mission is consistent with our mission of being a thought-leader for the industry,” said Stephen D. Susano, Chief Operating Officer, New York Hedge Fund Roundtable.

“As new regulations emerge, such as the SEC’s requirement that advisors supply evidence of their educational background, more professionals are seeking quality programs to demonstrate the depth and breadth of their industry knowledge,” said Florence Lombard, CEO of the CAIA Association. “The CAIA program has a rigorous curriculum and the designation certifies mastery of alternative investment concepts, tools and practices, and promotes adherence to high standards of professional conduct. We are very pleased the New York Hedge Fund Roundtable endorses the CAIA designation and has partnered with us to offer its members an incentive to earn the designation.”

To qualify for the designation, professionals must successfully pass both the CAIA Level I and Level II exams. The CAIA exams are held twice a year, in March and September, making it possible for candidates to earn the designation within a year of starting the program.


Press Release


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t